deltatrials
Completed NA INTERVENTIONAL 2-arm NCT01150955

Potential Beneficial Effects of Resveratrol

Potential Beneficial Effects of Resveratrol on Obesity, Metabolic Syndrome and Inflammation - Emphasis on Description of the Molecular Biology Underpinning the Interplay Between Calorie Restriction, SIRT1, STAT5 and the GH/IGF-I Axis

Sponsor: The Ministry of Science, Technology and Innovation, Denmark

Conditions Metabolic Syndrome Obesity
Interventions Placebo Resveratrol
Last updated: Mar 21, 2012 Started: Oct 31, 2010 Primary completion: Nov 30, 2011 Completion: Nov 30, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01150955, this NA trial focuses on Metabolic Syndrome and Obesity and remains completed. Sponsored by The Ministry of Science, Technology and Innovation, Denmark, it has been updated 0 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

No change history available.

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • The Ministry of Science, Technology and Innovation, Denmark
  • University of Aarhus
Data source: University of Aarhus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations